Scaffold Diversity Synthesis and Its Application in Probe and Drug Discovery.
暂无分享,去创建一个
Kamal Kumar | Miguel Garcia-Castro | Stefan Zimmermann | Muthukumar G Sankar | Kamal Kumar | M. García-Castro | M. Sankar | S. Zimmermann
[1] Adrià Cereto-Massagué,et al. Molecular fingerprint similarity search in virtual screening. , 2015, Methods.
[2] Stuart L. Schreiber,et al. Stereoselective Synthesis of over Two Million Compounds Having Structural Features Both Reminiscent of Natural Products and Compatible with Miniaturized Cell-Based Assays , 1998 .
[3] Herbert Waldmann,et al. Biology‐Oriented Synthesis of a Tetrahydroisoquinoline‐Based Compound Collection Targeting Microtubule Polymerization , 2013, Chembiochem : a European journal of chemical biology.
[4] Herbert Waldmann,et al. Chemical biology--identification of small molecule modulators of cellular activity by natural product inspired synthesis. , 2008, Chemical Society reviews.
[5] L. A. Marcaurelle,et al. Diversity-oriented synthesis of 13- to 18-membered macrolactams via ring-closing metathesis. , 2011, The Journal of organic chemistry.
[6] C. Dobson. Chemical space and biology , 2004, Nature.
[7] Kieron M. G. O'Connell,et al. Diversity-oriented synthesis of bicyclic and tricyclic alkaloids. , 2010, Chemical communications.
[8] D. Sheppard,et al. Classifying shape coverage in fragment libraries using a fingerprinting approach. , 2015, Bioorganic & medicinal chemistry letters.
[9] Stuart L Schreiber,et al. Skeletal diversity via a branched pathway: efficient synthesis of 29 400 discrete, polycyclic compounds and their arraying into stock solutions. , 2002, Journal of the American Chemical Society.
[10] Patrick W. Faloon,et al. Synthesis of a novel suppressor of beta-cell apoptosis via diversity-oriented synthesis. , 2011, ACS medicinal chemistry letters.
[11] Adam Nelson,et al. Towards the realisation of lead-oriented synthesis. , 2014, Drug discovery today.
[12] Jérôme Hert,et al. Quantifying Biogenic Bias in Screening Libraries , 2009, Nature chemical biology.
[13] Phil S. Baran,et al. Scalable total synthesis and biological evaluation of haouamine A and its atropisomer. , 2009, Journal of the American Chemical Society.
[14] Suzanne Fergus,et al. Skeletal diversity construction via a branching synthetic strategy. , 2006, Chemical communications.
[15] William L. Jorgensen. Herausforderungen für die akademische Wirkstoff‐Forschung , 2012 .
[16] G. Carter,et al. Harnessing the biosynthetic capacity of marine-derived organisms. , 2011, Bioorganic & medicinal chemistry.
[17] Herbert Waldmann,et al. Biology-oriented synthesis of a natural-product inspired oxepane collection yields a small-molecule activator of the Wnt-pathway , 2011, Proceedings of the National Academy of Sciences.
[18] K. Nicolaou. The emergence of the structure of the molecule and the art of its synthesis. , 2013, Angewandte Chemie.
[19] Jie Liang,et al. Creation and manipulation of common functional groups en route to a skeletally diverse chemical library , 2011, Proceedings of the National Academy of Sciences.
[20] M. Cummings,et al. Structure-based macrocyclization yields hepatitis C virus NS5B inhibitors with improved binding affinities and pharmacokinetic properties. , 2012, Angewandte Chemie.
[21] W. Matsui,et al. Molecular Pathways Molecular Pathways : The Hedgehog Signaling Pathway in Cancer , 2012 .
[22] Herbert Waldmann,et al. Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[23] Stefan Wetzel,et al. Biology-oriented synthesis. , 2011, Angewandte Chemie.
[24] Robert M. Williams,et al. Enantiomeric natural products: occurrence and biogenesis. , 2012, Angewandte Chemie.
[25] Chien-Hung Yeh,et al. Scalable synthesis of cortistatin A and related structures. , 2011, Journal of the American Chemical Society.
[26] H. Waldmann,et al. Catalytic enantioselective synthesis of functionalized tropanes reveals novel inhibitors of hedgehog signaling. , 2013, Angewandte Chemie.
[27] S. Wetzel,et al. Biologie‐orientierte Synthese (BIOS) , 2011 .
[28] Zainab Jagani,et al. Unraveling the therapeutic potential of the Hedgehog pathway in cancer , 2013, Nature Medicine.
[29] K. Nicolaou. Vom Aufkommen des Molekülkonzepts zur Kunst der Molekülsynthese , 2013 .
[30] H. Oikawa,et al. Biogenetically inspired synthesis and skeletal diversification of indole alkaloids. , 2014, Nature chemistry.
[31] Paul Ha-Yeon Cheong,et al. C-H···O non-classical hydrogen bonding in the stereomechanics of organic transformations: theory and recognition. , 2013, Organic & biomolecular chemistry.
[32] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[33] H. Waldmann,et al. A natural product inspired tetrahydropyran collection yields mitosis modulators that synergistically target CSE1L and tubulin. , 2013, Angewandte Chemie.
[34] William L Jorgensen,et al. Challenges for academic drug discovery. , 2012, Angewandte Chemie.
[35] Phil S. Baran,et al. Academia–Industry Symbiosis in Organic Chemistry , 2015, Accounts of chemical research.
[36] D. Spring,et al. A diversity-oriented synthesis strategy enabling the combinatorial-type variation of macrocyclic peptidomimetic scaffolds , 2015, Organic & biomolecular chemistry.
[37] A. Zografos,et al. Accessing the structural diversity of pyridone alkaloids: concise total synthesis of rac-citridone A. , 2011, Organic letters.
[38] Herbert Waldmann,et al. Principles, implementation, and application of biology-oriented synthesis (BIOS) , 2010, Biological chemistry.
[39] Nathan T. Ross,et al. An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. , 2010, Journal of the American Chemical Society.
[40] Z. Derewenda,et al. The occurrence of C-H...O hydrogen bonds in proteins. , 1995, Journal of molecular biology.
[41] John S. Delaney,et al. Assessing the ability of chemical similarity measures to discriminate between active and inactive compounds , 1996, Molecular Diversity.
[42] D. Swinney,et al. How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.
[43] Victor J Hruby. Organic chemistry and biology: chemical biology through the eyes of collaboration. , 2009, The Journal of organic chemistry.
[44] R. Hicklin,et al. Synthesis of complex and diverse compounds through ring distortion of abietic acid. , 2014, Angewandte Chemie.
[45] P. Baran,et al. Scalable, enantioselective synthesis of germacrenes and related sesquiterpenes inspired by terpene cyclase phase logic. , 2012, Angewandte Chemie.
[46] Andreas Bender,et al. Anti-MRSA agent discovery using diversity-oriented synthesis. , 2008, Angewandte Chemie.
[47] José L Medina-Franco,et al. Molecular Scaffold Analysis of Natural Products Databases in the Public Domain , 2012, Chemical biology & drug design.
[48] J. A. Grant,et al. A modular lead-oriented synthesis of diverse piperazine, 1,4-diazepane and 1,5-diazocane scaffolds. , 2014, Organic & biomolecular chemistry.
[49] Obdulia Rabal,et al. Novel Scaffold Fingerprint (SFP): Applications in Scaffold Hopping and Scaffold-Based Selection of Diverse Compounds , 2015, J. Chem. Inf. Model..
[50] Stuart L Schreiber,et al. Generating Diverse Skeletons of Small Molecules Combinatorially , 2003, Science.
[51] Fabrizio Giordanetto,et al. The European lead factory—an experiment in collaborative drug discovery , 2016, Journal of Medicines Development Sciences.
[52] Stefan Wetzel,et al. Bioactivity-guided mapping and navigation of chemical space. , 2009, Nature chemical biology.
[53] K. C. Nicolaou. 2 . Current State of Affairs in the Drug Discovery and Development Process , 2014 .
[54] Gisbert Schneider,et al. Scaffold diversity of natural products: inspiration for combinatorial library design. , 2008, Natural product reports.
[55] J. A. Grant,et al. Modular, gold-catalyzed approach to the synthesis of lead-like piperazine scaffolds. , 2013, Organic letters.
[56] H. Schöler,et al. Discovery of neuritogenic compound classes inspired by natural products. , 2013, Angewandte Chemie.
[57] David J Newman,et al. Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.
[58] Gregory P. Tochtrop,et al. Molecular library synthesis using complex substrates: expanding the framework of triterpenoids. , 2013, The Journal of organic chemistry.
[59] A. Strasser,et al. The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.
[60] Anang A Shelat,et al. Scaffold composition and biological relevance of screening libraries. , 2007, Nature chemical biology.
[61] John P. Overington,et al. The promise and peril of chemical probes. , 2015, Nature chemical biology.
[62] Hyeong Jun An,et al. Estimating the size of the human interactome , 2008, Proceedings of the National Academy of Sciences.
[63] A. Sands,et al. In vivo drug target discovery: identifying the best targets from the genome. , 2001, Current opinion in biotechnology.
[64] Peter Willett,et al. The Calculation of Molecular Structural Similarity: Principles and Practice , 2014, Molecular informatics.
[65] David R Spring,et al. Diversity-oriented synthesis: producing chemical tools for dissecting biology. , 2012, Chemical Society reviews.
[66] Nathan Brown,et al. On scaffolds and hopping in medicinal chemistry. , 2006, Mini reviews in medicinal chemistry.
[67] A. Bender,et al. Diversity-oriented synthesis of macrocyclic peptidomimetics , 2011, Proceedings of the National Academy of Sciences.
[68] Xiaoguang Lei,et al. Total syntheses of (-)-huperzine Q and (+)-lycopladines B and C. , 2015, Angewandte Chemie.
[69] A. Ganesan. The impact of natural products upon modern drug discovery. , 2008, Current opinion in chemical biology.
[70] Shengzheng Wang,et al. Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents. , 2015, Journal of medicinal chemistry.
[71] David R Spring,et al. A strategy for the diversity-oriented synthesis of macrocyclic scaffolds using multidimensional coupling. , 2013, Nature chemistry.
[72] D. Spring,et al. Diversity-oriented synthesis of drug-like macrocyclic scaffolds using an orthogonal organo- and metal catalysis strategy. , 2014, Angewandte Chemie.
[73] P. Arya,et al. Natural product-like chemical space: search for chemical dissectors of macromolecular interactions. , 2005, Current opinion in chemical biology.
[74] Adam Nelson,et al. A unified lead-oriented synthesis of over fifty molecular scaffolds. , 2015, Organic & biomolecular chemistry.
[75] Adam Nelson,et al. Activity-Directed Synthesis with Intermolecular Reactions: Development of a Fragment into a Range of Androgen Receptor Agonists , 2015, Angewandte Chemie.
[76] Phil S. Baran,et al. Scalable, stereocontrolled total syntheses of (±)-axinellamines A and B. , 2011, Journal of the American Chemical Society.
[77] Stuart L Schreiber,et al. Organic synthesis toward small-molecule probes and drugs , 2011, Proceedings of the National Academy of Sciences.
[78] David R Spring,et al. Diversity-oriented synthesis. , 2009, Chemical record.
[79] R. Hicklin,et al. A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products. , 2013, Nature chemistry.
[80] Xiaoguang Lei,et al. Total Syntheses of Lycopodium Alkaloids ( + )-Fawcettimine , ( + )-Fawcettidine , and ( )-8-Deoxyserratinine * * , 2011 .
[81] Siegfried R. Waldvogel,et al. Diversitäts‐orientierte Synthese von polycyclischen Gerüsten durch Umsetzung eines von 2,4‐Dimethylphenol abgeleiteten anodischen Zwischenproduktes , 2011 .
[82] S. Schreiber,et al. Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.
[83] J. Scannell,et al. Diagnosing the decline in pharmaceutical R&D efficiency , 2012, Nature Reviews Drug Discovery.
[84] Adam Nelson,et al. A conceptual framework for analysing and planning synthetic approaches to diverse lead-like scaffolds. , 2013, Chemical communications.
[85] Xiaoguang Lei,et al. Collective Synthesis of Lycopodium Alkaloids and Tautomer Locking Strategy for the Total Synthesis of (−)-lycojapodine A , 2022 .
[86] H. Waldmann,et al. Discovery of inhibitors of the Wnt and Hedgehog signaling pathways through the catalytic enantioselective synthesis of an iridoid-inspired compound collection. , 2013, Angewandte Chemie.
[87] William Lewis,et al. Synthesis of natural-product-like scaffolds in unprecedented efficiency via a 12-fold branching pathway , 2011 .
[88] P. Baran,et al. C–H Methylation of Heteroarenes Inspired by Radical SAM Methyl Transferase , 2014, Journal of the American Chemical Society.
[89] K C Nicolaou,et al. Organic synthesis: the art and science of replicating the molecules of living nature and creating others like them in the laboratory , 2014, Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[90] A. Nadin,et al. Leitstruktur‐orientierte Synthese: eine Alternative für die Synthesechemie , 2012 .
[91] Stuart L Schreiber,et al. A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.
[92] Phil S Baran,et al. Scalable enantioselective total synthesis of taxanes. , 2011, Nature chemistry.
[93] A. Chang,et al. Hedgehog pathway inhibition and the race against tumor evolution , 2012, The Journal of cell biology.
[94] Carol A. Mulrooney,et al. Build/couple/pair strategy for the synthesis of stereochemically diverse macrolactams via head-to-tail cyclization. , 2012, ACS combinatorial science.
[95] D. Pompliano,et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.
[96] D. Rogers,et al. Using Extended-Connectivity Fingerprints with Laplacian-Modified Bayesian Analysis in High-Throughput Screening Follow-Up , 2005, Journal of biomolecular screening.
[97] Martin D. Burke,et al. Eine Strategie für die Diversitäts‐orientierte Synthese , 2004 .
[98] William D. Foulkes,et al. Challenges to cancer control by screening , 2003, Nature Reviews Cancer.
[99] Carol A. Mulrooney,et al. Diversity-Oriented Synthesis-Facilitated Medicinal Chemistry: Toward the Development of Novel Antimalarial Agents , 2014, Journal of medicinal chemistry.
[100] Jing Zhang,et al. Diversity-oriented synthesis of Lycopodium alkaloids inspired by the hidden functional group pairing pattern , 2014, Nature Communications.
[101] Stefan Wetzel,et al. The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..
[102] M. White. Adding Aliphatic C–H Bond Oxidations to Synthesis , 2012, Science.
[103] José L. Medina-Franco,et al. Scaffold Diversity Analysis of Compound Data Sets Using an Entropy-Based Measure , 2009 .
[104] Xiao‐Yu Liu,et al. Generating skeletal diversity from the C19 -diterpenoid alkaloid deltaline: a ring-distortion approach. , 2015, Chemistry.
[105] A. Hyman,et al. Natural product-inspired cascade synthesis yields modulators of centrosome integrity. , 2012, Nature chemical biology.
[106] Didier Rognan,et al. Assessing the Scaffold Diversity of Screening Libraries , 2006, J. Chem. Inf. Model..
[107] C. Tse,et al. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax) , 2015, Cell Death and Disease.
[108] Peter Ertl,et al. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds. , 2006, Journal of medicinal chemistry.
[109] Stephen P. Hale,et al. The exploration of macrocycles for drug discovery — an underexploited structural class , 2008, Nature Reviews Drug Discovery.
[110] Markus Schürmann,et al. Branching cascades: a concise synthetic strategy targeting diverse and complex molecular frameworks. , 2011, Angewandte Chemie.
[111] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[112] Claude Ostermann,et al. De novo branching cascades for structural and functional diversity in small molecules , 2015, Nature Communications.
[113] Gavin Harper,et al. Drug rings database with web interface. A tool for identifying alternative chemical rings in lead discovery programs. , 2003, Journal of medicinal chemistry.
[114] N. Winssinger,et al. Following the Lead from Nature: Divergent Pathways in Natural Product Synthesis and Diversity-Oriented Synthesis , 2013 .
[115] G. Wei,et al. Single Diastereomer of a Macrolactam Core Binds Specifically to Myeloid Cell Leukemia 1 (MCL1). , 2014, ACS medicinal chemistry letters.
[116] Shridhar H. Thorat,et al. Catalyst-dependent selectivity in the relay catalytic branching cascade. , 2015, Chemistry.
[117] Peter Ertl,et al. Intuitive Ordering of Scaffolds and Scaffold Similarity Searching Using Scaffold Keys , 2014, J. Chem. Inf. Model..
[118] S. O’Connor,et al. Chemistry and biology of monoterpene indole alkaloid biosynthesis. , 2006, Natural product reports.
[119] H. Waldmann,et al. Cascade syntheses routes to the centrocountins. , 2013, Chemistry.
[120] Andreas Bender,et al. Plate-Based Diversity Selection Based on Empirical HTS Data to Enhance the Number of Hits and Their Chemical Diversity , 2009, Journal of biomolecular screening.
[121] Erik Sahai,et al. Illuminating the metastatic process , 2007, Nature Reviews Cancer.
[122] Patrick W. Faloon,et al. Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake. , 2015, Bioorganic & medicinal chemistry letters.
[123] David R Spring,et al. Gemmacin B: bringing diversity back into focus. , 2008, Organic & biomolecular chemistry.
[124] Herbert Waldmann,et al. Bioactivity-guided navigation of chemical space. , 2010, Accounts of chemical research.
[125] Susan M. Schlenner,et al. Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells , 2013, Nature Immunology.
[126] Martin Brassard,et al. Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic. , 2011, Journal of medicinal chemistry.
[127] Derek S. Tan,et al. Diversity-oriented synthesis: exploring the intersections between chemistry and biology , 2005, Nature chemical biology.
[128] David R Spring,et al. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. , 2010, Nature communications.
[129] M. White,et al. Total synthesis and study of 6-deoxyerythronolide B by late-stage C-H oxidation. , 2009, Nature chemistry.
[130] G. Carter,et al. Natural products and Pharma 2011: strategic changes spur new opportunities. , 2011, Natural product reports.
[131] Herbert Waldmann,et al. Charting Biological and Chemical Space: PSSC and SCONP as Guiding Principles for the Development of Compound Collections Based on Natural Product Scaffolds , 2006 .
[132] David J Newman,et al. Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.
[133] Hans-Jörg Roth,et al. There is no such thing as 'diversity'! , 2005, Current opinion in chemical biology.
[134] Miklos Feher,et al. Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry , 2003, J. Chem. Inf. Comput. Sci..
[135] M. White,et al. On the macrocyclization of the erythromycin core: preorganization is not required. , 2011, Angewandte Chemie.
[136] Adam Nelson,et al. A systematic approach to diverse, lead-like scaffolds from α,α-disubstituted amino acids. , 2015, Chemical communications.
[137] Ricardo Macarron,et al. Enhancements of screening collections to address areas of unmet medical need: an industry perspective. , 2010, Current opinion in chemical biology.
[138] H. Schöler,et al. Highly enantioselective catalytic synthesis of neurite growth-promoting secoyohimbanes. , 2013, Chemistry & biology.
[139] B. Sridhar,et al. Relay catalytic branching cascade: a technique to access diverse molecular scaffolds. , 2013, Angewandte Chemie.
[140] Channa K. Hattotuwagama,et al. Lead-oriented synthesis: a new opportunity for synthetic chemistry. , 2012, Angewandte Chemie.
[141] William Lewis,et al. Combining two-directional synthesis and tandem reactions. Part 21: Exploitation of a dimeric macrocycle for chain terminus differentiation and synthesis of an sp(3)-rich library. , 2015, Bioorganic & medicinal chemistry.
[142] K. Saxena,et al. Discovery of a new class of inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B by biology-oriented synthesis. , 2008, Angewandte Chemie.
[143] P G Pelicci,et al. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases , 2011, Oncogene.
[144] A. H. Lipkus,et al. Structural Diversity of Organic Chemistry. a Scaffold Analysis of the Cas Registry , 2022 .
[145] H. Waldmann,et al. Biology-oriented synthesis of stereochemically diverse natural-product-derived compound collections by iterative allylations on a solid support. , 2007, Chemistry.
[146] É. Marsault,et al. Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery. , 2011, Journal of medicinal chemistry.
[147] Robert M. Williams,et al. Enantiomere Naturstoffe: Vorkommen und Biogenese , 2012 .
[148] D. Spring,et al. Discovery of a quorum sensing modulator pharmacophore by 3D small-molecule microarray screening. , 2010, Organic & biomolecular chemistry.
[149] A. Trabocchi,et al. Diversity-Oriented Synthesis as a Tool for Chemical Genetics , 2014, Molecules.
[150] P. Arya,et al. Exploring new chemical space by stereocontrolled diversity-oriented synthesis. , 2005, Chemistry & biology.
[151] S. Waldvogel,et al. Diversity-oriented synthesis of polycyclic scaffolds by modification of an anodic product derived from 2,4-dimethylphenol. , 2011, Angewandte Chemie.
[152] Stuart L. Schreiber,et al. Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections , 2011, Proceedings of the National Academy of Sciences.
[153] P. Baran,et al. Scalable Total Syntheses of (-)-Hapalindole U and (+)-Ambiguine H. , 2015, Tetrahedron.
[154] Lorenz M Mayr,et al. The Future of High-Throughput Screening , 2008, Journal of biomolecular screening.
[155] Mark Johnson,et al. Algorithm for Naming Molecular Equivalence Classes Represented by Labeled Pseudographs , 2001, J. Chem. Inf. Comput. Sci..
[156] H. Waldmann,et al. Entwicklung einer neuen Klasse von Inhibitoren der Proteintyrosinphosphatase‐B aus Mycobacterium tuberculosis durch Biologie‐orientierte Synthese (BIOS) , 2008 .
[157] H. Waldmann,et al. Biology-oriented combined solid- and solution-phase synthesis of a macroline-like compound collection. , 2009, Chemistry.
[158] Adam Nelson,et al. Efficient discovery of bioactive scaffolds by activity-directed synthesis , 2014, Nature Chemistry.